Company: BKYI
Filing Date: 2025-10-30
Form Type: 8-K
Source: 0001437749-25-032448
Chunk: 1

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-10-30
Form: 8-K
Item: Item 1.01
Chunk 1
---
 services, the Company agreed to pay Maxim an aggregate cash fee equal to 6.0% of the gross proceeds received by the Company under the Warrant Exercise Agreement.

The foregoing descriptions of the Warrant Exercise Agreement and the New Warrants are not complete and are qualified in their entirety by reference to the full text of the form of Warrant Exercise Agreement and the form of Common Stock Purchase Warrant, copies of which are attached hereto as Exhibits 10.1 and 10.4, respectively, to this Current Report on Form 8-K and incorporated by reference herein.

Streeterville Exchange Agreements

On October 27, 2025, the Company entered into two Exchange Agreements (the “ Exchange Agreements”) with Streeterville Capital, LLC (“ Lender”), to whom the Company previously issued that certain Secured Promissory Note, dated June 24, 2024, in the original principal amount of $2,360,000 (the “ Original Note”).

Pursuant to the Exchange Agreements, the Company and Lender agreed to (i) partition from the Original Note two new Promissory Notes (the “ Partitioned Notes”) in the original principal amounts of $261,841 and $66,150, respectively (collectively, the “ Exchange Amounts”), (ii) cause the outstanding balance of the Original Note to be reduced by $327,991, the aggregate principal amount of the Partitioned Notes, and (iii) exchange (the “ Exchange”) the Partitioned Notes for an aggregate of 429,027 shares (the “ Exchange Shares”) of the Company’s Common Stock. As a result of the Exchange Agreements, the Original Note has been paid in full.

The foregoing description of the Exchange Agreements is not complete and is qualified in its entirety by reference to the full text of the Exchange Agreements, copies of which are attached hereto as Exhibits 10.2 and 10.3, respectively, to this Current Report on Form 8-K and incorporated by reference herein.

Item 3.02 Unregistered Sale of Equity Securities.